Author | Year | N (CTO lesions) | Prior CABG, (%) | Prior CABG in successful PCI group (%) | Prior CABG in unsuccessful PCI group (%) | Overall, retrograde (%) | Overall, technical Success (%) | Overall, major complications (%) | Overall, fluoroscopy time (min) | Overall, contrast use (ml) |
---|---|---|---|---|---|---|---|---|---|---|
Olivari et al13 | 2003 | 376 | 5.0 | 4.5 | 6.9 | NR | 77.2 | 5.1 | NR | NR |
Rathore et al14 | 2009 | 904 | 12.6 | 11.9 | 17.7 | 17 | 87.5 | 1.9 | NR | NR |
Morino et al12 | 2010 | 528 | 9.6 | NR | NR | 26 | 86.6 | NR | 45 (1–301)* | 293 (53–1,097)* |
Mehran et al10 | 2011 | 1791 | 15.9 | 13.6 | 20.9 | NR | 68.0 | NR | NR | 448±229 |
Galassi et al11 | 2011 | 1983 | 14.6 | NR | NR | 14 | 82.9 | 1.8 | 42.3±47.4† | 313±184† |
Jones et al15 | 2012 | 836 | 10.2 | 16.5 | 7.4 | NR | 69.6 | 2.3 | NR | NR |
Present study | 2012 | 1363 | 37.0 | 35.0 | 50.8 | 34 | 85.5 | 1.8 | 42±29† | 294±158† |
*median (range)
†mean±SD
CABG, coronary artery bypass graft surgery; CTO, chronic total occlusions; NR, not reported; PCI, percutaneous coronary intervention.